Comparative Analysis of Myelofibrosis Treatment Outcomes with the Use of Ruxolitinib Versus Ruxolitinib with Subsequent Allogeneic Hematopoietic Stem Cell Transplantation

Aim. To comparatively analyze myelofibrosis treatment outcomes with the use of ruxolitinib versus ruxolitinib with subsequent allogeneic hematopoietic stem cell transplantation (allo-HSCT) as well as to assess the efficacy of ruxolitinib in pre- and post-transplantation periods. Materials & Metho...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mariya Vladimirovna Barabanshchikova, E. V. Morozova, Yu. Yu. Vlasova, T. L. Gindina, A. V. Evdokimov, I. M. Barkhatov, V. V. Baikov, I. O. Ivanova, T. A. Rudakova, E. A. Bakin, I. S. Moiseev, A. D. Kulagin
Formato:	Artigo
Idioma:	Russo
Publicado em:	Practical Medicine Publishing House 2021-01-01
Colecção:	Клиническая онкогематология
Assuntos:	myelofibrosis ruxolitinib allogeneic hematopoietic stem cell transplantation
Acesso em linha:	https://bloodjournal.ru/index.php/coh/article/view/167
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!